AJANTPHARM — Ajanta Pharma Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹334.26bn
- IN₹327.02bn
- IN₹42.09bn
- 99
- 13
- 70
- 68
Annual cashflow statement for Ajanta Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 6,640 | 9,002 | 9,095 | 7,453 | 11,139 |
| Depreciation | |||||
| Non-Cash Items | -249 | -8.2 | -332 | 5 | -520 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -2,780 | -4,391 | -4,395 | -848 | -4,122 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 4,568 | 5,763 | 5,620 | 7,918 | 7,851 |
| Capital Expenditures | -2,394 | -1,716 | -1,488 | -1,745 | -1,524 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 150 | -1,108 | 747 | -3,851 | 2,178 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -2,244 | -2,824 | -741 | -5,596 | 654 |
| Financing Cash Flow Items | -96.5 | -407 | -759 | -34.4 | -44.5 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -1,286 | -3,183 | -4,600 | -1,079 | -10,511 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1,037 | -244 | 279 | 1,243 | -2,006 |